1. Ali H, Rousseau J, Ghaffari MA, van Lier JE (1988): Synthesis, receptor binding, and tissue distribution of (17α,20E)- and 17α,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diol. J Med Chem 31:1946–1950.
2. Ali H, Rousseau J, van Lier JE (1993a): 7a-Methyl- and 11β-ethoxy-substitution of [125I]-16α-iodoestradiol: Effect on estrogen receptor-mediated target tissue up-take. J Med Chem 36:264–271.
3. Ali H, Rousseau J, Gantchev TG, van Lier JE (1993b): 2- and 4-Fluorinated 16α-[125I]iodoestradiol derivatives: Synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake. J Med Chem 36:4255–4263.
4. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC (1979): Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39:1447–1454.
5. Arunachalam T, Longcope C, Caspi E (1979): Iodoestrogens, syntheses, and interaction with uterine receptors. J Biol Chem 254:5900–5905.